glp-1 retatrutide New obesity drug, retatrutide, shows added benefits Reta GLP-3R (Retatrutide) 10mg |

37 Obesity increases the risk of comorbidities like hypertension, DM2, hyperlipidemia, stroke, and some cancers, leading to higher mortality rates, primarily from cardiovascular complications

[DOI] [PubMed] [Google Scholar] 145.Elia L., Contu R., Quintavalle M., Varrone F., Chimenti C., Russo M.A., Cimino V., De Marinis L., Frustaci A., Catalucci D., et al

a ) Data are presented as box plots min-max (median), cytosolic fraction at 3 M, tGSH ( Trkb Penk-WT 1.0 0.03

Panahi Y, Khalili N, Sahebi E, Namazi S, Simental-Menda LE, Majeed M, et al

This suggests that even viral infections rely on a shared pathophysiological link through altered metabolism and the induction of SLD to drive carcinogenesis (Wang and Zhang, 2023

Vicerrectora de Investigacin y Doctorados de la Universidad San Sebastian VRIDFAPPE20/01 (LM)